Mutagenicity of combined immunosuppressantsYU, Y; YUZAWA, K; OTSUKA, M et al.Transplantation proceedings. 1993, Vol 25, Num 5, pp 2959-2960, issn 0041-1345Conference Paper

Monitoring mutagennogo zagrâzneniâ malyh rekFOMIČEVA, A.N; PROHOROVA, I.M.Vodnye resursy. 2005, Vol 32, Num 3, pp 347-351, issn 0321-0596, 5 p.Article

N-nitrosodiethylamine mutagenicity at low concentrationsFORTES AIUB, Claudia Alessandra; RIBEIRO PINTO, Luis Felipe; FELZENSZWALB, Israel et al.Toxicology letters. 2003, Vol 145, Num 1, pp 36-45, issn 0378-4274, 10 p.Article

Derivation and validation of toxicophores for mutagenicity predictionKAZIUS, Jeroen; MCGUIRE, Ross; BURSI, Roberta et al.Journal of medicinal chemistry (Print). 2005, Vol 48, Num 1, pp 312-320, issn 0022-2623, 9 p.Article

Mutagenicity of the antischistosomal agent amoscanate and its hydrolytic and related para substituted 4-nitrodiphenylamine productsGUPTA, R. L; KAUR, I. P; JUNEJA, T. R et al.Medical science research. 1992, Vol 20, Num 10, pp 365-368, issn 0269-8951Article

Modeling, Synthesis and Biological Evaluation of Potential Retinoid X Receptor (RXR) Selective Agonists: Novel Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene)WAGNER, Carl E; JURUTKA, Peter W; TRAN, Ivy T et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 19, pp 5950-5966, issn 0022-2623, 17 p.Article

Genotoxicity of α-asarone analoguesKARWICKA, Ewa; MARCZEWSKA, Jadwiga; ANUSZEWSKA, Elzbieta et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 11, pp 6069-6074, issn 0968-0896, 6 p.Article

Cationic hydrogels of PEG crosslinked by a hydrolyzable polyrotaxane for cartilage regenerationOOYA, Tooru; ICHIA, Takahiro; FURUBAYASHI, Tomoyuki et al.Reactive & functional polymers. 2007, Vol 67, Num 11, pp 1408-1417, issn 1381-5148, 10 p.Article

Effect of process distillation on mutagenicity and cell-transformation activity of solvent-refined, coal-derived liquidsPELROY, R. A; FRAZIER, M. E; LATER, D. W et al.Fuel (Guildford). 1985, Vol 64, Num 5, pp 639-643, issn 0016-2361Article

Comparative chemical composition and biological activity of single- and two-stage coal liquefaction process streamsWILSON, B. W; PELROY, R. A; MAHLUM, D. D et al.Fuel (Guildford). 1984, Vol 63, Num 1, pp 46-55, issn 0016-2361Article

Electron-correlation based externally predictive QSARs for mutagenicity of nitrated-PAHs in Salmonella typhimurium TA100VIKAS, Reenu.Ecotoxicology and environmental safety (Print). 2014, Vol 101, pp 42-50, issn 0147-6513, 9 p.Article

Heteroaryl urea inhibitors of fatty acid amide hydrolase: Structure―mutagenicity relationships for arylamine metabolitesTICHENOR, Mark S; KEITH, John M; WILSON, Sandy J et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 24, pp 7357-7362, issn 0960-894X, 6 p.Article

7-Azabicyclo[2.2.1]heptane as a structural motif to block mutagenicity of nitrosaminesOHWADA, Tomohiko; ISHIKAWA, Satoko; MINE, Yusuke et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 8, pp 2726-2741, issn 0968-0896, 16 p.Article

A topological sub-structural approach of the mutagenic activity in dental monomers. 1. Aromatic epoxidesPEREZ GONZALEZ, Maykel; MORALES HELGUERA, Aliuska; RUIZ, Reinaldo Molina et al.Polymer (Guildford). 2004, Vol 45, Num 8, pp 2773-2779, issn 0032-3861, 7 p.Article

Composition and mutagenicity of PAHs associated with urban airborne particles in Córdoba, ArgentinaCARRERAS, Hebe A; ELENA CALDERON-SEGURA, Marıa; GOMEZ-ARROYO, Sandra et al.Environmental pollution (1987). 2013, Vol 178, pp 403-410, issn 0269-7491, 8 p.Article

A new structural alert for benzimidazoles: 2,6-Dimethylphenyl substituents increase mutagenic potential and time-dependent CYP3A4 inhibition riskKWAK, Youngshin; COPPOLA, Gary; STADELMANN, Pascal et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 5, pp 1422-1424, issn 0960-894X, 3 p.Article

New class of potent antitumor acylhydrazone derivatives containing furanZINING CUI; YING LI; YUN LING et al.European journal of medicinal chemistry. 2010, Vol 45, Num 12, pp 5576-5584, issn 0223-5234, 9 p.Article

Halogenated derivatives QSAR model using spectral moments to predict haloacetic acids (HAA) mutagenicityPEREZ-GARRIDO, Alfonso; PEREZ GONZALEZ, Maykel; GARRIDO ESCUDERO, Amalio et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 10, pp 5720-5732, issn 0968-0896, 13 p.Article

Biopartitioning micellar chromatography to predict mutagenicity of aromatic aminesTORRES-CARTAS, S; MARTIN-BIOSCA, Y; VILLANUEVA-CAMANAS, R. M et al.European journal of medicinal chemistry. 2007, Vol 42, Num 11-12, pp 1396-1402, issn 0223-5234, 7 p.Article

Contribution à l'amélioration de la qualité sanitaire du blé en cours de stockage. I - Suivi de la formation des mycotoxines de stockage: le point sur nos connaissances : Mycotoxines de stockage des blés = Improving the plant health quality of wheat in storage. I - Monitoring storage mycotoxins: a status report on current awarenessPFOHL-LESZKOWICZ, Annie; CASTEGNARO, Marcel; BEDOURET, Sabine et al.Phytoma, la défense des végétaux. 2001, Num 541, pp 24-30, issn 1164-6993Article

Mutagenicity, dioxin-like activity and bioaccumulation of alkylated picene and chrysene derivatives in a German ligniteMEYER, Wiebke; SEILER, Thomas-Benjamin; CHRIST, Andreas et al.Science of the total environment. 2014, Vol 497-98, pp 634-641, issn 0048-9697, 8 p.Article

Attic dust assessment near a wood treatment plant: Past air pollution and potential exposureCORONAS, Mariana Vieira; BAVARESCO, Jovana; VAZ ROCHA, Jocelita Aparecida et al.Ecotoxicology and environmental safety (Print). 2013, Vol 95, pp 153-160, issn 0147-6513, 8 p.Article

Concentration, Origin and Health Hazard from Fine Particle-Bound PAH at Three Characteristic Sites in Southern PolandROGULA-KOZLOWSKA, Wioletta; KOZIELSKA, Barbara; KLEJNOWSKI, Krzysztof et al.Bulletin of environmental contamination and toxicology. 2013, Vol 91, Num 3, pp 349-355, issn 0007-4861, 7 p.Article

1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor XaPINTO, Donald J. P; ORWAT, Michael J; ROSSI, Karen A et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 15, pp 4141-4147, issn 0960-894X, 7 p.Article

A duplicated nitrotienyl derivative with antimycobacterial activity : synthesis, X-ray crystallography, biological and mutagenic activity testsRANDO, D. G; DORIGUETTO, A. C; DA SILVA, C. H. Tomich De Paula et al.European journal of medicinal chemistry. 2006, Vol 41, Num 10, pp 1196-1200, issn 0223-5234, 5 p.Article